🇺🇸 FDA
Pipeline program

VY-AADC01

PD-1101

Phase 1 mab completed

Quick answer

VY-AADC01 for Parkinson's Disease is a Phase 1 program (mab) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Parkinson's Disease
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials